What’s Going On With Virgin Galactic Stock After Reverse Split?
Virgin Galactic Holdings shares are trading lower Monday after the company effected a 1-for-20 reverse stock split. Here's a look at the details:
Aaron’s, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
U.S. stocks were mostly lower, with the Dow Jones index falling around 0.2% on Monday. Shares of The…
What’s Going On With Celsius Holdings Stock Today?
Celsius Holdings Inc (NASDAQ:CELH) shares are trading lower Monday. Roth MKM analyst Sean McGowan maintained Celsius Holdings with a Buy rating on Monday, but cut the firm's price target from $96 to $87.
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hypertension. Despite being well tolerated, AV-101 failed to meet primary and secondary endpoints. Enrollment for Phase 3 is halted.
Why Agriforce Stock Is Up
AgriFORCE Growing Systems shares are trading higher Monday after the company announced a $1 million share repurchase program. Here's a look at what's going on:
Micron Stock Is Moving Higher Monday: What’s Going On?
BofA Securities analyst Vivek Arya maintained Micron with a Buy rating on Monday and raised the price target from $144 to $170. Susquehanna analyst Mehdi Hosseini also maintained Micron with a Positive rating and raised the price target from $143 to $185.
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday?
Mustang Bio shares soar 190.9% on high trading volume as Phase 1/2 trial data for CAR T-cell therapy MB-106 shows positive results.
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure Patients
Marinus Pharmaceuticals announces Phase 3 RAISE trial results for IV ganaxolone in refractory status epilepticus.
Autodesk Stock Jumps As Activist Investor Pushes For Margin Improvement, Board Changes: The Details
Autodesk Inc (NASDAQ:ADSK) shares are trading higher Monday after activist investor Starboard Value purchased a stake of more than $500 million in the company and wrote a letter to shareholders pushing for changes.
What’s Going On With Ovid Therapeutics After Takeda’s Two Phase 3 Epilepsy Studies Fail?
Takeda Pharmaceutical reveals Phase 3 study data for Soticlestat (TAK-935) in treating Dravet and Lennox-Gastaut syndromes. In 2021, Ovid Therapeutics out licensed the drug.